Afuco™ Anti-Human PLA2G10 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-PLA2G10 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The novel antibodies against human group X secreted phospholipase A2 (sPLA2-X) can be used for the treatment of cardiovascular disease.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-702CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | PLA2G10 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at –20 or -70°C upon receipt. Divide antibody into aliquots prior usage and avoid multiple freeze-thaw cycles. |